Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (301-310 of 434) with videos related to

Pageof 44
Sort By:
Clinical and Experimental Rheumatology|November 17, 2020
Efficacy of leflunomide in the treatment of vasculitisNoura Mustapha, Lillian Barra, Simon Carette, et al.
The New England Journal of Medicine|May 18, 2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Praveen Akuthota, David Jayne, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Arthritis Care & Research|December 1, 2011
Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)Megan E B Clowse, Susannah C Copland, Tsung-Cheng Hsieh, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Guide to bone health and disease in cystic fibrosisRobert M Aris, Peter A Merkel, Laura K Bachrach, et al.
The Journal of Rheumatology|April 3, 2016
The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell ArteritisTanaz A Kermani, David Cuthbertson, Simon Carette, et al.
Arthritis and Rheumatism|April 29, 2006
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept TrialJohn H Stone, Janet T Holbrook, Matthew A Marriott, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working GroupLara S Chapman, Begonya Alcacer-Pitarch, John D Pauling, et al.
Journal of Autoimmunity|July 20, 2019
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitisAlvise Berti, Roscoe Warner, Kent Johnson, et al.
RMD Open|March 29, 2023
Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphismMarta Casal Moura, Zuoming Deng, Stephen R Brooks, et al.
Pageof 44

Showing results (301-310 of 434) with videos related to

Sort By:
Pageof 44
Clinical and Experimental Rheumatology|November 17, 2020
Efficacy of leflunomide in the treatment of vasculitisNoura Mustapha, Lillian Barra, Simon Carette, et al.
The New England Journal of Medicine|May 18, 2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Praveen Akuthota, David Jayne, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Arthritis Care & Research|December 1, 2011
Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)Megan E B Clowse, Susannah C Copland, Tsung-Cheng Hsieh, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Guide to bone health and disease in cystic fibrosisRobert M Aris, Peter A Merkel, Laura K Bachrach, et al.
The Journal of Rheumatology|April 3, 2016
The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell ArteritisTanaz A Kermani, David Cuthbertson, Simon Carette, et al.
Arthritis and Rheumatism|April 29, 2006
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept TrialJohn H Stone, Janet T Holbrook, Matthew A Marriott, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working GroupLara S Chapman, Begonya Alcacer-Pitarch, John D Pauling, et al.
Journal of Autoimmunity|July 20, 2019
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitisAlvise Berti, Roscoe Warner, Kent Johnson, et al.
RMD Open|March 29, 2023
Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphismMarta Casal Moura, Zuoming Deng, Stephen R Brooks, et al.
Pageof 44